Best practices for evaluation of bone marrow in nonclinical toxicity studies

Veterinary Clinical Pathology

Volumn 40, Issue 2, 2011, Pages 119-134

  Reagan, William J ^a   Irizarry Rovira, Armando ^b   Poitout Belissent, Florence ^c   Bolliger, Anne Provencher ^c   Ramaiah, Shashi K ^a   Travlos, Greg ^d   Walker, Dana ^e   Bounous, Denise ^e   Walter, Gail ^f  

^a PFIZER INC   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c CHARLES RIVER LABORATORIES   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e BRISTOL MYERS SQUIBB   (United States)

^f NONE

Author keywords

Best practice; Bone marrow; Cytology; Flow cytometry; Histopathology

Indexed keywords

EID: 79957894124     PISSN: 02756382     EISSN: 1939165X     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2011.00323.x     Document Type: Article

References (88)

1. Travlos GS. Normal structure, function, and histology of the bone marrow. Toxicol Pathol. 2006a;34:548-565.
2. Olson H, Betton G, Robinson D, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol. 2000;32:56-67.
3. Gasper PW. The hematopoietic system. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology. Philadelphia, PA: Lippincott Williams and Wilkins; 2000:63-78.
4. Meyer DJ, Harvey JW. Veterinary Laboratory Medicine. Interpretation and Diagnosis. Philadelphia, PA: W. B. Saunders; 1998.
5. Weiss L, Geduldig U. Barrier cells: Stromal regulation of hematopoiesis and blood cell release in normal and stressed murine bone marrow. Blood. 1991;78:975-990.
6. Food and Drug Administration, Center for Food Safety and Nutrition (November 2003). Toxicological principles for the safety assessment of food ingredients. Redbook 2000, pp. 1-15.
7. Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biological Evaluation and Research (April 2006). Guidance for industry: S8 Immunotoxicity studies for human pharmaceuticals, pp. 1-13.
8. European Medicines Agency, Committee for Proprietary Medicinal Products (May 2006). Notes for guidance of immunotoxicity studies for human pharmaceuticals, pp. 1-9.
9. European Medicines Agency, Committee for Proprietary Medicinal Products (July 2000). Note for guidance on repeated dose toxicity, pp. 1-9.
10. Weingand K, Brown G, Hall R, et al. Harmonization of animal clinical pathology testing in toxicity and safety studies. Fundam Appl Toxicol. 1996;29:198-201.
11. Yakuji Nippo L. Japan's and ICH guidelines for new drug registration with harmonized tripartite guidelines. Tokyo: Yakuji Nippo, LTD; 1999.
12. Food and Drug Administration, Center for Veterinary Medicine (May 2007). Guidance for industry: Target animal safety for veterinary pharmaceutical products (VICH GL43 Draft Guidance), pp. 1-14.
13. Environmental Protection Agency 1988 Health Effects Test Guidelines OPPTS 870.4100 Chronic Toxicity, pp. 1-16.
14. Environmental Protection Agency, (August 1998). Health Effects Test Guidelines, OPPTS 870.4200, Carcinogenicity, pp. 1-15.
15. European Medicines Agency, Committee for Proprietary Medicinal Products (July 2002). Note for guidance of carcinogenic potential, pp. 1-8.
16. Food and Drug Administration, Center for Drug Evaluation and Research and Center for Biological Evaluation and Research (July 1997). Guidance for industry: S1B (ICH) Testing for carcinogenicity of pharmaceuticals pp. 1-10.
17. Cline MJ, Maronpot RR. Variations in the histologic distribution of rat bone marrow cells with respect to age and anatomic site. Toxicol Pathol. 1985;13:349-355.
18. Weiss DJ. Histopathology of canine nonneoplastic bone marrow. Vet Clin Pathol. 1986;15:7-12.
19. Ogawa Y, Matsumoto K, Kamata E, Ikeda Y, Kaneko T. Effect of feed restriction on the peripheral blood and bone marrow cell counts of Wistar rats. Jikken Dobutsu. 1985;34:407-416.
20. Seki M, Yamaguchi K, Marumo H, Imai K. Effects of food restriction on reproductive and toxicological parameters in rats-in search of suitable feeding regimen in long-term tests. J Toxicol Sci. 1997;22:427-437.
21. Levin S, Semler D, Ruben Z. Effects of two weeks of feed restriction on some common toxicologic parameters in Sprague-Dawley rats. Toxicol Pathol. 1993;21:1-14.
22. Borelli P, Barros FE, Nakajima K, et al. Protein-energy malnutrition halts hemopoietic progenitor cells in G0/G1 cell cycle stage, thereby altering cell production rates. Braz J Med Biol Res. 2009;42:523-530.
23. Hill RC, Lewis DD, Randell SC, et al. Effect of mild restriction of food intake on the speed of racing Greyhounds. Am J Vet Res. 2005;66:1065-1070.
24. Lawler DF, Ballam JM, Meadows R, et al. Influence of lifetime food restriction on physiological variables in Labrador retriever dogs. Exp Gerontol. 2007;42:204-214.
25. Yoffey J, Courtice F. Lymphatics, Lymph and the Lymphomyeloid Complex. London: Academic Press; 1970.
26. Andreasen CB, Roth JA. Neutrophil function abnormalities. In: Feldman BF, Zinkle JG., Jain NC, eds. Schalm's Veterinary Hematology. Philadelphia, PA: Lippincott Williams and Wilkins; 2000:356-365.
27. Boudreaux MK. Acquired platelet dysfunction. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology. Philadelphia, PA: Lippincott, Williams and Wilkens; 2000:496-508.
28. Bono CD, Elwell MR, Rogers K. Necropsy techniques with standard collection and trimming of tissues. In: Krinke GJ, ed. The Laboratory Rat. New York, NY: Academic Press; 2000:569-600.
29. Feldman DB, Seely JC. Necropsy Guide: Rodents and the Rabbit. Boca Raton, FL: CRC Press; 1988.
30. Fero M (2005). Histology of Mouse Tissues. Fred Hutchinson Cancer Research Center.
31. Goodwin BT, Jerome CP. Iliac biopsy for histomorphometric analysis of trabecular bone in cynomolgus monkeys and baboons. Lab Anim Sci. 1987;37:213-216.
32. Grindem CB. Bone marrow biopsy and evaluation. Vet Clin North Am Sm Anim Pract. 1989;19:669-696.
33. Klein HJ, Seedor G, Frankenfield DL, Thompson DD. Method for transilial bone biopsy in baboons. J Am Vet Med Assoc. 1991;198:1977-1979.
34. Tyler RD, Cowell RL. Bone marrow. In: Cowell RL, Tyler JW, eds. Diagnostic Cytology of the Dog and Cat. Goleta, CA: American Veterinary Publications; 1989.
35. Kushida T, Inaba M, Ikebukuro K. Comparison of bone marrow cells harvested from various cynomolgus monkeys at various ages by perfusion or aspiration methods: A preclinical study of human bone marrow transplantation. Stem Cells. 2002;20:155-162.
36. Penny RH, Carlisle CH. The bone marrow of the dog: A comparative study of biopsy material obtained from the iliac crest, rib and sternum. J Small Anim Pract. 1970;11:727-734.
37. Bain BJ, Clark DM, Lampert IA, Wilkins BS. Bone Marrow Pathology. Malden, MA: Blackwell Science; 2001.
38. Burns WA, Bretschneider A. Thin Is In: Plastic Embedding of Tissue for Light Microscopy. Chicago, IL: American Society of Clinical Pathologists; 1990.
39. Hedrich HJ, Bullock G. The Laboratory Mouse. Amsterdam: Elsevier Academic Press; 2004.
40. Kiernan JA. Histological and Histochemical Methods: Theory and Practice. New York, NY: Pergamon Press; 1990.
41. Weiss DJ. A review of the techniques for preparation of histopathologic sections of bone marrow. Vet Clin Pathol. 1987;16:90-94.
42. Callis G, Sterchi D. Decalcification of bone: Literature review and practical study of various decalcifying agents, methods, and their effects on bone histology. J Histotechnol. 1998;21:49-58.
43. Beckstead JH, Halverson PS, Ries CA, Bainton DF. Enzyme histochemistry and immunohistochemistry on biopsy specimens of pathologic human bone marrow. Blood. 1981;57:1088-1098.
44. Bennett HS, Wyrick AD, Lee SW, McNeil JH. Science and art in preparing tissues embedded in plastic for light microscopy, with special reference to glycol methacrylate, glass knives and simple stains. Stain Tech. 1976;51:71-97.
45. Moosavi H, Lichtman MA, Donnelly JA, Churukian CJ. Plastic-embedded human marrow biopsy specimens: Improved histochemical methods. Arch Pathol Lab Med. 1981;105:269-273.
46. Lowenstine LJ. A primer of primate pathology: Lesions and nonlesions. Toxicol Pathol. 2003;31 (Suppl):92-102.
47. Ito T, Fumio C, Sasaki S, Ando T, Miyajima H. Spontaneous lesions in cynomolgus monkeys used in toxicity studies. Exp Anim. 1992;41:455-469.
48. Frith CH, Ward JM, Chandra M, Losco PE. 2000 Non-proliferative lesions of the hematopoietic system in rats. HL-1. In Guides for Toxicologic Pathology, pp. 1-22. STP/ARP/AFIP, Washington, DC.
49. Geldof AA, Rimmelzwaan GF, Langevoort HL. Histology of the bone marrow antibody response. An immunocytochemical study during the secondary response in mouse and rat. Virchows Arch B Cell Pathol Incl Mol Pathol. 1983;44:65-72.
50. Andrews MC. The hematopoietic system. In: Torton J, Hooson J, eds. Target Organ Pathology: A Basic Text. Bristol, PA: Taylor and Francis; 1998:177-205.
51. Buckley PJ. Examination and interpretation of bone marrow biopsies and aspirate smears. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silverstein LE, McGlave P, eds. Hematology, Basic Principals and Practice. New York, NY: Churchill Livingstone; 1995:2214-2222.
52. Elmore SA. Enhanced histopathology of the bone marrow. Toxicol Pathol. 2006;34:666-686.
53. Travlos GS. Histopathology of bone marrow. Toxicol Pathol. 2006b;34:566-598.
54. Valli VE, McGrath JP, Chu I. Hematopoietic system. In: Haschek WM, Rousseaux CG, Wallig MA, eds. Handbook of Toxicologic Pathology. San Diego, CA: Academic Press; 2002:667-679.
55. Wickramasinghe SN, Beatty C, Shiels S, Tomlinson DR, Harris JR. Ultrastructure of the bone marrow in HIV infection: Evidence of dyshaemopoiesis and stromal cell damage. Clin Lab Haematol. 1992;14:213-229.
56. Haley P, Perry R, Ennulat D, et al. STP position paper: Best practice guideline for the routine pathology evaluation of the immune system. Toxicol Pathol. 2005;33:404-408.
57. Smith CA, Andrews CM, Collard JK, Hall DE, Walker AK. Color Atlas of Comparative Diagnostic and Experimental Hematology. Barcelona, Spain: Wolfe Publishing; 1994.
58. Freeman KP. Bone marrow evaluation. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's Veterinary Hematology. Philadelphia, PA: Lippincott Williams and Wilkins; 2000:29-32.
59. Harvey JW. Atlas of Veterinary Hematology. Philadelphia, PA: W. B. Saunders; 2001.
60. Provencher Bolliger A. Cytological evaluation of bone marrow in rats: Indications, methods, and normal morphology. Vet Clin Pathol. 2004;33:58-67.
61. Ryan D. Examination of themarrow. In: Buetler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, eds. Williams Hematology. New York, NY: McGraw-Hill; 2001:17-25.
62. Criswell KA, Bleavins MR, Zielinski D, Zandee JC. Comparison of flow cytometric and manual bone marrow differentials in Wistar rats. Cytometry. 1998;32:9-17.
63. Criswell KA, Bleavins MR, Zielinski D, Zandee JC, Walsh KM. Flow cytometric evaluation of bone marrow differentials in rats with pharmacologically induced hematologic abnormalities. Cytometry. 1998;32:18-27.
64. Criswell KA, Sulkanen AP, Hochbaum AF, Bleavins MR. Effects of phenylhydrazine or phlebotomy on peripheral blood, bone marrow and erythropoietin in Wistar rats. J Appl Toxicol. 2000;20:25-34.
65. Kakiuchi S, Ohara S, Ogata S, Miura D, Kasahara Y, Izawa Y. Flow cytometric analysis on lineage-specific cell surface antigens of rat bone marrow to seek potential myelotoxic biomarkers: Status after repeated dose of 5-fluorouracil. Toxicol Sci. 2004;29:101-111.
66. Kurata M, Iidaka T, Hamada Y, Horii I. Simultaneous measurement of nucleated cell counts and cellular differentials in rat bone marrow examination using flow cytometer. J Toxicol Sci. 2007;32:289-299.
67. Saad A, Palm M, Widell S, Reiland S. Differential analysis of rat bone marrow by flow cytometry. Comp Haematol Int. 2000;10:97-101.
68. Schomaker SJ, Clemo FA, Amacher DE. Analysis of rat bone marrow by flow cytometry following in vivo exposure to cyclohexanone oxime or daunomycin HCl. Toxicol Appl Pharmacol. 2002;185:48-54.
69. Shah VO, Civin CI, Loken MR. Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis. J Immunol. 1988;140:1861-1867.
70. Weiss DJ, Blauvelt M, Sykes J, McCenahan D. Flow cytometric evaluation of canine bone marrow differential cell counts. Vet Clin Pathol. 2000;29:97-104.
71. Zhao S, Valdez R, Baker D, et al. (2005). Development of a rat flow cytometric bone marrow assay. In Clinical Flow Cytometry Meeting, Savanah, Georgia.
72. Zhao S, Heward JE, Cockerell GL, Mattes BW, Johnson CW (2003). Flow cytometry method to evaluate bone marrow toxicity in the rat. In Society of Toxicology Annual Meeting.
73. Weiss DJ. Flow cytometric evaluation of canine bone marrow based on intracytoplasmic complexity and CD45 expression. Vet Clin Pathol. 2004;33:96-101.
74. Erickson-Miller CL, May RD, Tomaszewski J, Osborn B, Murphy MJ, Page JG, Parchment RE. Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro. Cancer Chemother Pharmacol. 1997;39:467-472.
75. McMullin MF, Buckley O, Magill MK, Irvine AE. Long-term bone marrow culture profiles in patients with myelodysplastic syndromes are not explicable by defective apoptosis. Leuk Res. 1998;22:735-740.
76. Fan F, Wood KV. Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol. 2007;5:127-136.
77. Slater K. Cytotoxicity tests for high-throughput drug discovery. Curr Opin Biotechnol. 2001;12:70-74.
78. Greenwalt DE, Szabo J, Manchel I. High throughput cell-based assay of hematopoietic progenitor differentiation. J Biomol Screen. 2001;6:383-392.
79. Alvi S, Lisak LA, Shetty VT. Novel in vitro culture and ultrastructural techniques to study the biology of myelodysplastic syndromes (MDS). Cancer Treat Res. 2001;108:65-79.
80. Burns WA, Yook CR. Plastic sections and ultrastructural techniques in the evaluation of bone marrow pathology. Hematol Oncol Clin North Am. 1988;2:525-536.
81. Chamberlain JK, Leblond PF, Weed RI. Reduction of advential cell cover and early direct effect of erythropoietin on bone marrow ultrastructure. Blood Cells. 1975;1:655-674.
82. Deldar A, Lewis H, Bloom J, Weiss L. Cephalosporininduced changes in the ultrastructure of canine bone marrow. Vet Pathol. 1988;25:211-218.
83. Kitajima M, Shigematsu M, Ogawa K, Sugihara H, Hotokebuchi T. Effects of glucocorticoid on adipocyte size in human bone marrow. Med Mol Morphol. 2007;40:150-156.
84. Okamatsu K, Kido H, Sato A, Watazu A, Matsuura M. Ultrastructure of the interface between titanium and surrounding tissue in rat tibiae. A comparison study on titanium-coated and -uncoated plastic implants. Clin Implant Dent Relat Res. 2007;9:100-111.
85. Rouselle S, Wicks J. Preparation of medical devices for evaluation. Toxicol Pathol. 2008;36:81-84.
86. Samsom JP, Hulstaert CE, Molenaar I, Nieweg HO. Fine structure of the bone marrow sinusoidal wall in idiopathic and drug-induced panmyelopathy. Acta Haematol. 1972;48:218-226.
87. Dykstra MJ, Reuss LE. Biological Electron Microscopy. Theory, Techniques and Troubleshooting. New York, NY: Plenum Press; 2003.
88. Hayat MA. Principles and Techniques of Electron Microscopy: Biological Applications. New York, NY: Cambridge University Press; 2000.